England’s National Health Service (NHS) announces new guidelines alerting the public of withdrawal problems associated with commonly-prescribed depression pills. The guidelines make it clear coming off SSRIs can cause long-lasting symptoms. NHS is England’s drug regulator and is similar to America’s FDA.

“We have amended the guideline to recognise the emerging evidence on the severity and duration of antidepressant withdrawal symptoms,” said Dr Paul Chrisp, director of the centre for guidelines at NICE, a watchdog for NHS.

SSRIs include Paroxetine (sold as Seroxat in the UK and Paxil in the US); Sertraline (sold as Lustrol in the UK and Zoloft in the US), and; Fluoxetine (sold as Sarafem in the UK and Prozac in the US).

Read the full story here.